Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average, structural decline.
Left:
||||
Year-over-year research & development expense growth
Latest
3.38%
↓ 96% below average
Average (9y)
75.84%
Historical baseline
Range
High:369.02%
Low:-62.91%
CAGR
-40.6%
Structural decline
| Period | Value |
|---|---|
| 2024 | 3.38% |
| 2023 | 93.15% |
| 2022 | -55.72% |
| 2021 | -62.91% |
| 2020 | 9.67% |
| 2019 | 84.32% |
| 2018 | 86.70% |
| 2017 | 68.68% |
| 2016 | 162.14% |
| 2015 | 369.02% |